One hundred and fifty patients presenting with small cell lung cancer (SCLC) 
Methods
One hundred and fifty consecutive patients with a tissue diagnosis of SCLC were assessed clinically at five hospitals participating in trials of chemotherapy for SCLC. Mean (SD) age was 64 (7 4) years and 79% were male. Thirty five per cent had limited disease, that is, confined to one hemithorax, or with bilateral hilar involvement. Eighty per cent were recruited to trials of chemotherapy, but all patients were assessed before the administration of cytotoxic drugs. Tissue diagnosis was achieved following fibreoptic bronchoscopy in 122 cases, of which 114 had a positive biopsy; the other eight were diagnosed on cytological examination of bronchial washings. Nine cases were diagnosed by sputum cytology alone, and eleven from other non-bronchoscopic biopsies. All patients had been given a diagnosis of SCLC, but four also had co-existent non-SCLC bronchogenic tumours.
A standard assessment protocol was used. Background information about the presentation of the tumour, and its diagnosis, was established from clinical case notes. Enquiry about past medical history and family history included direct questions about diabetes, thyroid disease, and neurological disease. Current and recent medication was recorded. Direct questions were asked to establish the presence or absence of weakness, anorexia, weight loss, dry mouth, sphincter difficulty, erectile impotence, diplopia, and ptosis. A detailed neurological assessment was performed, but in 20 cases this was limited by the patient's inability to stand. Tendon reflexes were elicited before assessment of muscle power, and, in subjects with diminished reflexes, again after 15 'One or more measures of weakness was present in 44% of subjects.
'Excluding inability to rise from squatting position.
objective proximal weakness, and inability to rise from a squatting position) were associated with each other (p < 0-001); symptomatic and proximal weakness were each associated with dry mouth (p < 0-001). These data are shown in the figure.
Other clinical parameters were mutually independent.
Abnormal cardiovascular reflexes were common: 11 % had a postural systolic blood pressure fall of >29 mmHg, with a borderline fall of 11-29 mmHg in a further 26%.'3 In 18% of subjects, the pulse rate failed to rise on standing.
LEMS was suspected from the clinical assessment in seven patients. Their details are shown in table 2. Six of these agreed to have EMG studies, and diagnostic features of LEMS were present in two; these two were also distinguished by their long histories of weakness, 11 and 17 months before the diagnosis of SCLC.
One patient had SSN. This 63 year old woman presented with a six month history of painful sensory loss in all four limbs, and also described dry mouth and weakness; examination revealed distal sensory loss to pain, and joint position sense impairment with sensory ataxia. Sensory action potentials were absent from right median, ulnar, radial, and sural nerves; motor conduction velocities were normal. Right ulnar CMAP was slightly reduced, at 7-0 mV, but there was no pathological increment. Elrington, Murray, Spiro, Newsom-Davis Twenty four subjects had sensory impairment, most commonly distal vibration sense loss, and 15 were areflexic. These two features were not significantly associated (0-01 < p < 0-05).
Four patients had ataxia of the trunk and limbs, of whom two had CT evidence of cerebellar brain metastases. In one case without radiological evidence of metastases, the ataxia was mild, in the other it was of sudden onset with subsequent improvement, and therefore attributed to stroke. Three patients had nystagmus, without ataxia.
In patients with LEMS and SSN, neurological symptoms antedated other manifestations of SCLC, but in none of these three patients was the correct neurological diagnosis suspected before recruitment to this survey. The 95% confidence interval for their combined prevalence was 0-4%. Dry mouth has been reported as a specific feature of LEMS, useful in the differential diagnosis from myasthenia gravis. 5 The presence of this symptom in 41% of SCLC patients limits its value in the diagnosis of weakness in patients known to have SCLC.
In this sample of 150 patients, the finding of weakness in 44% of the subjects is likely to be representative of all SCLC patients. The lower incidence of LEMS and of SSN is clearly subject to a large error, and the 95% confidence interval of 0-4% implies that, on these data, any survey of SCLC patients might yield no cases.
The 95% confidence interval could be narrowed by studying a larger sample of SCLC patients; but if our data are representative of all cases of SCLC, a sample size of 1000 SCLC patients would be required to reduce the range of the confidence interval to + 1%.
Previous studies have addressed this question, either on a smaller scale or in retrospective series. Lambert's group'8 estimated that LEMS affected 6% of SCLC subjects, on the basis of case findings in an estimated total lung cancer population among whom 16% were thought to have SCLC. This 16% is an underestimate: a review of 449 old pathological specimens found that SCLC had been diagnosed in 7% of all lung cancer patients, but 22% had this cell type according to modern criteria.'9 Lambert's SCLC population was therefore larger than his estimate, thus reducing the apparent prevalence of LEMS in his series, which was also likely to have been influenced by selection bias. It was acknowledged that the 6% figure was a rough estimate, and seemed inconsistent with the data of Balz"8 who studied 29 SCLC patients electrophysiologically and found no cases of LEMS. Similarly, Croft and Wilkinson,20 in a prospective series, found no cases of "myasthenic neuromyopathy" among 319 cases of lung cancer, of whom 25% would have had SCLC.
More recent, prospective studies, have been smaller than our series. An electrophysiological study of 71 SCLC patients detected two cases of LEMS.'4 A clinical study found two cases among 35 patients with SCLC.20 A recent retrospective necropsy series of 85 SCLC patients contained five with LEMS;22 but LEMS patients are more likely to have a necropsy than non-LEMS SCLC patients.
If the present series is added to previous Table 3 Reported prevalence of LEMS among SCLC patients
